Summit Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $751.2M
Liabilities Breakdown FY2025
Total Liabilities: $92.3M
Asset Breakdown
Total Assets: $751.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $225.3M | 30.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 0.1% |
| Goodwill | $2.0M | 0.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $522.9M | 69.6% |
Liabilities Breakdown
Total Liabilities: $92.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $20.3M | 22.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $72.0M | 78.0% |